Paul Hideyo Hayashi
United States Food and Drug Administration · 211 works · 10,480 citations · h-index 51
Top works
- The natural history of nonalcoholic fatty liver disease: a clinical histopathological study
- ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
- Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
- Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
- Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features
- Causality Assessment in Drug-Induced Liver Injury Using A Structured Expert Opinion Process: Comparison to the Roussel-Uclaf Causality Assessment Method
- Hepatitis C Virus Is Detected in a Monocyte/Macrophage Subpopulation of Peripheral Blood Mononuclear Cells of Infected Patients
- Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations
- Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury
- Causality Assessment in Drug-Induced Liver Injury
- A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
- Liver Transplantation for Hepatocellular Carcinoma
- Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD
- Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus
- Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset
- Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death
- Liver Injury From Tumor Necrosis Factor-α Antagonists: Analysis of Thirty-four Cases
- Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients
- Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era
- Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010